![](/img/cover-not-exists.png)
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
Assouline, S., Culjkovic, B., Cocolakis, E., Rousseau, C., Beslu, N., Amri, A., Caplan, S., Leber, B., Roy, D.-C., Miller, W. H., Borden, K. L. B.Volume:
114
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2009-02-205153
Date:
July, 2009
File:
PDF, 461 KB
english, 2009